Predictive factors for live birth in autologous in vitro fertilization cycles in women aged 40 years and older

1 Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore: Williams &Wilkins, 1994:809-39. Speroff L Glass RH Kase NG Clinical gynecologic endocrinology and infertility 5th ed Baltimore Williams &Wilkins 1994809 39Search in Google Scholar

2 American College of Obstetricians and Gynecologists Committee on Gynecolocic Practice and Practice Committee. Female age-related fertility decline. Committee opinion 589. Feril Steril. 2014;101:6334. doi: 10.1016/j.fertnstert.2013.12.032. American College of Obstetricians and Gynecologists Committee on Gynecolocic Practice and Practice Committee Female age-related fertility decline Committee opinion 589. Feril Steril 20141016334 10.1016/j.fertnstert.2013.12.032Open DOISearch in Google Scholar

3 Balasch J, Gratacos E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012;24:187-93. doi: 10.1097/GCO.0b013e3283517908. Balasch J Gratacos E Delayed childbearing: effects on fertility and the outcome of pregnancy Curr Opin Obstet Gynecol 201224187 93 10.1097/GCO.0b013e3283517908Open DOISearch in Google Scholar

4 Hassold T, Hall H, Hunt P. The origine of human aneuploidy: where we have been, were we are going. Hum Mol Genet. 2007;16:203-8. doi: 10.1093/humrep/ddm243. Hassold T Hall H Hunt P The origine of human aneuploidy: where we have been, were we are going Hum Mol Genet 200716203 8 10.1093/humrep/ddm243Open DOISearch in Google Scholar

5 Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod. 2004;19:1548-53. doi: 10. 1093/humrep/deh304. Leridon H Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment Hum Reprod 2004191548 53 10. 1093/humrep/deh304Open DOISearch in Google Scholar

6 Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, et al. ESHRE Capri Workshop Group. Fertility and aging. Hum Repord Update. 2005;11:261-76. doi: 10.1093/humupd/dmi006. Baird DT Collins J Egozcue J Evers LH Gianaroli L Leridon H et al ESHRE Capri Workshop Group Fertility and aging. Hum Repord Update 200511261 76 10.1093/humupd/dmi006Open DOISearch in Google Scholar

7 Goldman MB, Thornton KL, Ryley D, Alper MM, Fung JL, Hornstein MD, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril. 2014;101:1574-81. doi: 10.1016/j. fertnstert.2014.03.012. Goldman MB Thornton KL Ryley D Alper MM Fung JL Hornstein MD et al A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T) Fertil Steril 20141011574 81 10.1016/j. fertnstert.2014.03.012Open DOISearch in Google Scholar

8 Armstrong S, Akande V. What is the best treatment option for infertile women aged 40 and over. J Assist Reprod Genet. 2013;30:667-71. doi: 10.1007/s10815-013-9980-6. Armstrong S Akande V What is the best treatment option for infertile women aged 40 and over J Assist Reprod Genet 201330667 71 10.1007/s10815-013-9980-6Open DOISearch in Google Scholar

9 Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, Reindollar RH. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril. 2005;84:435-45. doi: 10.1016/j.fertnstert. 2005.02.020. Klipstein S Regan M Ryley DA Goldman MB Alper MM Reindollar RH One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above Fertil Steril 200584435 45 10.1016/j.fertnstert. 2005.02.020Open DOISearch in Google Scholar

10 Tsafrir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older. Reprod BioMed Online. 2007;14:348-55. Tsafrir A Simon A Revel A Reubinoff B Lewin A Laufer N Retrospective analysis of 1217 IVF cycles in women aged 40 years and older Reprod BioMed Online 200714348 5510.1016/S1472-6483(10)60878-4Search in Google Scholar

11 Hipp H, Crawford S, Kawwass JF, Boulet SL, Grainger DA, Kissin DM, et al. National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older. J Assist Reprod Genet. 2017;34:885-9. doi: 10.1007/s10815-017-0926-2. Hipp H Crawford S Kawwass JF Boulet SL Grainger DA Kissin DM et al National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older J Assist Reprod Genet 201734885 9 10.1007/s10815-017-0926-2547654128455751Open DOISearch in Google Scholar

12 Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J. Assisted reproduction in women over 40 years of age: how old is too old? Reprod Biomed Online. 2009;19:599-603. Hourvitz A Machtinger R Maman E Baum M Dor J Levron J Assisted reproduction in women over 40 years of age: how old is too old? Reprod Biomed Online 200919599 60310.1016/j.rbmo.2009.04.002Search in Google Scholar

13 Serour G, Mansour R, Serour A, Abulghar M, Amin Y, Kamal O, et al. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologuos oocytes in women aged 40 years or above. Fertil Steril. 2010;94:1707-12. doi: 10.1016/j.fertnstert.2009.09.044. Serour G Mansour R Serour A Abulghar M Amin Y Kamal O et al Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologuos oocytes in women aged 40 years or above Fertil Steril 2010941707 12 10.1016/j.fertnstert.2009.09.044Open DOISearch in Google Scholar

14 Klitzman RL. How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization. Fertil Steril. 2016;106:216-24. doi: 10.1016/j.fertnstert.2016.03.030. Klitzman RL How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Fertil Steril 2016106216 24 10.1016/j.fertnstert.2016.03.030Open DOISearch in Google Scholar

15 Alviggi C, Humaidan P, Howles CM, Tredway D, Hillieret SG. Biological versus chronological ovarian age: Implications for assisted reproductive technology. Reprod Biol Endocrinol. 2009;7:101. doi: 10.1186/1477-7827-7-101. Alviggi C Humaidan P Howles CM Tredway D Hillieret SG Biological versus chronological ovarian age: Implications for assisted reproductive technology Reprod Biol Endocrinol 20097101 10.1186/1477-7827-7-101Open DOISearch in Google Scholar

16 Ethics Committee of American Society for Reproductive Medicine. Fertility treatment when the prognosis is very poor or futile: a committee opinion. Fertil Steril. 2012;98:e6-9. doi: 10.1016/j. fertnstert.2012.03.045. Ethics Committee of American Society for Reproductive Medicine Fertility treatment when the prognosis is very poor or futile: a committee opinion Fertil Steril 201298e6 9 10.1016/j. fertnstert.2012.03.045Open DOISearch in Google Scholar

17 Knez J, Kovačič B, Medved M, Vlaisavljević V. What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols? Reprod Biol Endocrinol. 2015;13:58. doi: 10.1186/s12958-015-0049-5. Knez J Kovačič B Medved M Vlaisavljević V What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols? Reprod Biol Endocrinol 20151358 10.1186/s12958-015-0049-5Open DOISearch in Google Scholar

18 Kovačič B, Vlaisavljević V, Reljič M, Čižek-Sajko M. Developmental capacity of different morphological types of day 5 human morulae and blastocysts. Reprod BioMed Online. 2004;8:687-94. Kovačič B Vlaisavljević V Reljič M Čižek-Sajko M Developmental capacity of different morphological types of day 5 human morulae and blastocysts Reprod BioMed Online 20048687 9410.1016/S1472-6483(10)61650-1Search in Google Scholar

19 Kovačič B, Vlaisavljević V. Importance of blastocyst morphology in selection for transfer. In: Wu B, ed. Advances in embryo transfer. Rijeka: Intech, 2012:161-77. Kovačič B Vlaisavljević V Importance of blastocyst morphology in selection for transfer Wu B Advances in embryo transfer Rijeka Intech 2012161 77Search in Google Scholar

20 Park HJ, Lyu SW, Seok HH, Yoon TK, Lee SW. Anti-Müllerian hormone levels as a predictor of clinical pregnancy in in vitro fertilization/ intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age. Clin Exp Reprod Med. 2015;42:143-8. doi: 10.5653/cerm.2015.42.4.143. Park HJ Lyu SW Seok HH Yoon TK Lee SW Anti-Müllerian hormone levels as a predictor of clinical pregnancy in in vitro fertilization/ intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age Clin Exp Reprod Med 201542143 8 10.5653/cerm.2015.42.4.143472459826816873Open DOISearch in Google Scholar

21 Lee Y, Lee HJ, Jayeon Kim, Lyu SW, Kim YS, Lee WS, et al. Predictive value of antral follicle count and serum anti-Müllerian hormone: which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Eur J Obstet Gynecol Reprod Biol. 2018;221:151-5. doi: 10.1016/j.ejogrb.2017.12.047. Lee Y Lee HJ Jayeon Kim Lyu SW Kim YS Lee WS et al Predictive value of antral follicle count and serum anti-Müllerian hormone: which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Eur J Obstet Gynecol Reprod Biol 2018221151 5 10.1016/j.ejogrb.2017.12.04729306180Open DOISearch in Google Scholar

22 Kim HO, Sung N, Song IO. Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 40 and over. Clin Exp Reprod Med. 2017;44:111-7. doi: 10.5653/ cerm.2017.44.2.111. Kim HO Sung N Song IO Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 40 and over Clin Exp Reprod Med 201744111 7 10.5653/ cerm.2017.44.2.111Open DOISearch in Google Scholar

23 Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768-74. doi: 10.1093/humrep/der106. Sunkara SK Rittenberg V Raine-Fenning N Bhattacharya S Zamora J Coomarasamy A Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum Reprod 2011261768 74 10.1093/humrep/der10621558332Open DOISearch in Google Scholar

24 Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev. 2018;2:CD012693. doi: 10.1002/14651858.CD012693.pub2. Lensen SF Wilkinson J Leijdekkers JA La Marca A Mol BWJ Marjoribanks J et al Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI) Cochrane Database Syst Rev 20182CD012693 10.1002/14651858.CD012693.pub2649106429388198Open DOISearch in Google Scholar

25 Haas J, Zilberger E, Machtinger R, Kedem A, Hourvitz A, Orvieto R. Do poor respoder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF? Gynecol Endocrinol. 2015;31:79-82. doi: 10.3109/09513590.2014.959919. Haas J Zilberger E Machtinger R Kedem A Hourvitz A Orvieto R Do poor respoder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF? Gynecol Endocrinol 20153179 82 10.3109/09513590.2014.95991925223892Open DOISearch in Google Scholar

26 Toftager M , Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod. 2017;32: 556-67. doi: 10.1093/humrep/dew358. Toftager M Bogstad J Løssl K Prætorius L Zedeler A Bryndorf T et al Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols Hum Reprod 201732 556 67 10.1093/humrep/dew35828130435Open DOISearch in Google Scholar

27 Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, et al. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI: how many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31:370-6. doi: 10.1093/humrep/dev316. Drakopoulos P Blockeel C Stoop D Camus M de Vos M Tournaye H et al Conventional ovarian stimulation and single embryo transfer for IVF/ICSI: how many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod 201631370 6 10.1093/humrep/dev31626724797Open DOISearch in Google Scholar

28 Gunnala V, Irani M, Melinck A, Rosenwaks Z, Spandorfer S. One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date. J Assist Reprod Genet. 2018;35:435-40. doi: 10.1007/s10815-017-1088-y. Gunnala V Irani M Melinck A Rosenwaks Z Spandorfer S One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date J Assist Reprod Genet 201835435 40 10.1007/s10815-017-1088-y590406129143944Open DOISearch in Google Scholar

29 McLernon DJ, Maheshwari A, Lee AJ, Bhattacharya S. Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178,898 women. Hum Reprod. 2016;31:572-81. doi: 10.1093/humrep/dev336. McLernon DJ Maheshwari A Lee AJ Bhattacharya S Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178,898 women Hum Reprod 201631572 81 10.1093/humrep/dev33626783243Open DOISearch in Google Scholar

30 Van Loendersloot LL, van Wely M, Limpens J, Bossuyt PMM, Repping S, van der Veen F. Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update. 2010;16:577-89. doi: 10.1093/humupd/dmq015. Van Loendersloot LL van Wely M Limpens J Bossuyt PMM Repping S van der Veen F Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis Hum Reprod Update 201016577 89 10.1093/humupd/dmq01520581128Open DOISearch in Google Scholar

31 Broekmans FJ. Testing for ovarian reserbve in assisted reproduction programs: the current point of view. Facts Views Vis Obgyn. 2009:1:79-87. Broekmans FJ Testing for ovarian reserbve in assisted reproduction programs: the current point of view Facts Views Vis Obgyn 2009179 87Search in Google Scholar

32 La Marca A, Ferraretti AP, Palermo R, Ubaldi FM. The use of ovarian reserve markers in IVF clinical practice: a national consensus. Gynecol Endocrinol. 2015;32:1-5. doi: 10.3109/09513590.2015.1102879. La Marca A Ferraretti AP Palermo R Ubaldi FM The use of ovarian reserve markers in IVF clinical practice: a national consensus Gynecol Endocrinol 2015321 5 10.3109/09513590.2015.110287926531067Open DOISearch in Google Scholar